Drug Design
Drug design, also known as rational drug design, is the process of creating new drugs based on the knowledge of the target and the interactions between the drug and the target. Drug design is a complex and extensive process that involves several steps such as target identification, lead discovery, lead optimization, and preclinical development. The first step in drug design is the identification of a specific target that is responsible for a particular disease. This target can be a protein or an enzyme that is involved in the disease process. Once the target is identified, the next step is to find a suitable lead compound that can interact with the target and modulate its activity. Lead discovery involves screening large libraries of compounds to find potential leads that can bind to the target. The lead compounds are then optimized to improve their potency, selectivity, and pharmacokinetic properties. Various computational and experimental techniques are used to optimize the lead compounds. Once the lead compounds have been optimized, they undergo preclinical development, which involves studies to determine their safety, efficacy, and pharmacokinetic properties. This includes animal studies, toxicology, and formulation development. Drug design is a critical process in the pharmaceutical industry as it is essential in discovering new drugs to treat a wide range of diseases. By using advanced pharmaceutical science and technology, drug design has become more efficient and effective in recent years, leading to the discovery of new drugs that have significantly improved patient outcomes.
← Journal of Advanced Pharmaceutical Science And Technology